Skip to main content
PHVS logo

Pharvaris N.V.

PHVSNASDAQHealthcareBiotechnology

$31.41Today:- (-)1Y +33.09%

As of Oct 23, 2026 close

Market cap
$2.14B
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$21.02$43.25
Volume (live)
-
Avg. volume (3M)
742.80K

Pharvaris (PHVS) Balance Sheet

As of Mar 31, 2026 (end of fiscal 2025), Pharvaris reported total assets of EUR 301.45M and total liabilities of EUR 30.18M. Shareholders' equity was EUR 271.27M, up 1.3% from EUR 267.76M a year earlier. Total debt stood at EUR 776.80K against EUR 291.68M in cash and short-term investments, a net cash position of EUR 290.90M. That puts debt-to-equity at 0.00, compared with 0.00 a year earlier.

Pharvaris Balance Sheet Analysis

Values in millions EUR

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Pharvaris N.V. (PHVS) - Annual data in millions EUR
BreakdownFY 2025FY 2025FY 2024FY 2024FY 2023FY 2023FY 2022FY 2022FY 2021FY 2020FY 2020FY 2019FY 2018
Period endingMar 2026Dec 2025Mar 2025Dec 2024Mar 2024Dec 2023Mar 2023Dec 2022Dec 2021Mar 2021Dec 2020Dec 2019Dec 2018
Current Assets
Cash and Cash Equivalents291.68291.68280.73280.73391.23391.23161.84161.84209.3598.6398.6320.335.39
Cash & Short-Term Investments291.68291.68280.73280.73391.23391.23161.84161.84209.3598.6398.6320.335.39
Accounts Receivable4.554.552.940.461.040.420.380.380.010.570.570.210.00
Inventory0.00-0.00-0.00-4.04-0.000.00-0.000.00
Other Current Assets2.942.945.755.755.585.580.580.580.011.750.540.050.02
Total Current Assets299.17299.17289.42289.42397.85397.85166.85166.85211.57100.95101.0520.585.43
Non-Current Assets
Property, Plant & Equipment (Net)1.401.401.481.480.460.460.630.630.350.050.050.010.00
Other Non-Current Assets0.000.890.000.470.000.390.000.260.000.00--0.00
Total Non-Current Assets2.292.291.961.960.840.840.890.890.520.15-0.010.00
Total Assets301.45301.45291.37291.37398.69398.69167.73167.73212.09101.10101.1020.605.43
Current Liabilities
Accounts Payable5.115.114.564.562.912.915.985.982.130.660.660.520.25
Short-Term Debt0.20-0.22-0.20-0.19-0.100.00-0.000.00
Accrued Liabilities-11.92-17.59-11.07-7.922.81-4.64--
Other Current Liabilities23.350.9417.590.6011.070.4310.890.464.274.47-1.400.23
Total Current Liabilities29.6029.6022.9722.9714.6014.6018.2218.226.995.315.311.920.48
Non-Current Liabilities
Long-Term Debt0.580.580.640.640.040.040.250.250.150.00-0.000.00
Other Non-Current Liabilities0.00-0.00-0.00-0.00-0.000.00-0.000.00
Total Non-Current Liabilities0.580.580.640.640.040.040.250.250.150.00-0.000.25
Total Liabilities30.1830.1823.6123.6114.6514.6518.4718.477.145.315.311.920.48
Stockholders' Equity
Common Stock7.837.836.536.536.276.274.064.063.980.240.050.130.10
Retained Earnings-579.60-579.60-402.26-402.26-265.92-265.92-164.19-164.19-87.57-44.46-44.46-18.47-10.45
Accumulated Other Comprehensive Income50.5050.5039.8539.8527.8827.8820.2120.219.801.981.980.390.28
Additional Paid-in Capital792.55792.55623.64623.64615.81615.81289.18289.18278.74138.03-36.7115.02
Shares Outstanding-65.21-54.38-52.29-33.8233.15----
Total Stockholders' Equity271.27271.27267.76267.76384.05384.05149.26149.26204.9595.7995.7918.674.95
Total Liabilities & Equity301.45301.45291.37291.37398.69398.69167.73167.73212.09101.10-20.605.43

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Pharvaris Balance Sheet

How much debt does Pharvaris have?

Pharvaris had total debt of EUR 776.80K as of Mar 31, 2026, against EUR 291.68M in cash and short-term investments. Its debt-to-equity ratio was 0.00. Total debt was EUR 861.47K a year earlier.

What are Pharvaris's total assets?

Pharvaris reported total assets of EUR 301.45M as of Mar 31, 2026, up 3.5% from EUR 291.37M a year earlier. Total liabilities were EUR 30.18M.

What is Pharvaris's shareholders' equity?

Pharvaris's shareholders' equity was EUR 271.27M as of Mar 31, 2026.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition